Why is cefotaxime preferred over ceftriaxone in neonates and patient with liver disease?
Ceftriaxone-induced biliary sludge is a solubility problem that occurs in patients receiving high-dose treatment (greater than or equal to 2 g).
The risk of developing ceftriaxone-associated biliary "pseudolithiasis" increases with increasing ceftriaxone dose and in patients with impaired gallbladder emptying.
Cefotaxime has renal excretion and therefore preferred over ceftriaxone.